Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Sleep Disorder Market Size Outlook: How Fast Will Revenue Grow Through 2030?

The sleep disorder market has experienced substantial expansion in recent times. Projections indicate it will grow from $33.32 billion in 2025 to $38.23 billion in 2026, registering a compound annual growth rate (CAGR) of 14.7%. The historical growth of this market is attributable to heightened awareness regarding sleep health, the escalating prevalence of insomnia and sleep apnea, the increasing adoption of sleep diagnostic services, a growing geriatric population, rising stress and lifestyle-related sleep disturbances, and the expanded usage of smartphones and wearable devices for monitoring sleep.

The sleep disorder market is anticipated to experience substantial expansion in the upcoming years, projected to attain a size of $65.51 billion by 2030, growing at a compound annual growth rate (CAGR) of 14.4%. This growth during the forecast period is driven by factors such as the expansion of telemedicine services for sleep disorders, increasing adoption of wearable sleep trackers, more widespread home-based diagnostic testing, the rise of cognitive behavioral therapy applications, and increased government initiatives aimed at sleep health awareness. Major developments expected over this period include advancements in wearable sleep monitoring devices, progress in home-based sleep diagnostic tools, evolution in AI-driven sleep analysis, innovations in non-invasive therapies for sleep apnea, new approaches in telemedicine for sleep consultation, and novel cognitive behavioral therapy apps.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30744&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

Sleep Disorder Market Industry Drivers: What Is Driving Revenue Growth?

Rising stress and anxiety levels are anticipated to propel the expansion of the sleep disorder market going forward. These levels signify the widespread occurrence of psychological strain and excessive worry within a population, frequently stemming from environmental, social, or economic pressures. Work-related demands, such as increased workloads, strict deadlines, and job instability, are contributing to the rise in stress and anxiety. They contribute to sleep disorders by disturbing typical sleep patterns and making it harder to initiate or maintain sleep. Furthermore, they impair overall health by hindering restorative sleep, resulting in fatigue, diminished cognitive function, and an elevated susceptibility to chronic illnesses. For instance, in May 2024, according to the American Psychiatric Association (APA), a US-based professional association, 43% of U.S. adults reported feeling more anxious in 2024 compared to the prior year, an increase from 37% in 2023 and 32% in 2022. Consequently, the escalating stress and anxiety levels are propelling the growth of the sleep disorder market.

Sleep Disorder Market Categorization By Product Type And Application

The sleep disorder market covered in this report is segmented –

1) By Disorder Type: Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Circadian Rhythm Disorders

2) By Treatment: Cognitive Behavioral Therapy, Medication Therapy, Psychiatric Treatment, Behavioral Treatment

3) By Diagnostic Method: Polysomnography, Home Sleep Testing, Actigraphy, Sleep Diaries, Questionnaires and Screening

4) By Distribution Channel: Retail Pharmacies, Online Sales, Hospital Pharmacies

5) By End-User: Hospitals And Sleep Centers, Home Care Settings, Academic

Subsegments:

1) By Insomnia: Acute Insomnia, Chronic Insomnia, Onset Insomnia, Maintenance Insomnia, Behavioral Insomnia, Medication-Induced Insomnia

2) By Sleep Apnea: Obstructive Sleep Apnea, Central Sleep Apnea, Complex Sleep Apnea Syndrome, Mild Sleep Apnea, Moderate Sleep Apnea, Severe Sleep Apnea, Pediatric Sleep Apnea, Treatment-Resistant Sleep Apnea

3) By Restless Legs Syndrome: Primary Restless Legs Syndrome, Secondary Restless Legs Syndrome, Mild Restless Legs Syndrome, Moderate Restless Legs Syndrome, Severe Restless Legs Syndrome, Intermittent Restless Legs Syndrome, Chronic Persistent Restless Legs Syndrome

4) By Narcolepsy: Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia, Pediatric Narcolepsy, Treatment-Resistant Narcolepsy, Secondary Narcolepsy

5) By Circadian Rhythm Disorders: Delayed Sleep Phase Disorder, Advanced Sleep Phase Disorder, Shift Work Sleep Disorder, Jet Lag Disorder, Irregular Sleep-Wake Rhythm Disorder, Non-24-Hour Sleep-Wake Disorder

#Sleep Disorder Market Growth Trends: What Is Influencing The Future Outlook?

Leading firms within the sleep disorder sector are prioritizing the creation of cutting-edge therapeutic innovations, including electrical vestibular nerve stimulation (VeNS) techniques, to offer non-pharmacological interventions aimed at improving sleep quality, normalizing circadian rhythms, and assisting individuals with chronic insomnia. The electrical vestibular nerve stimulation (VeNS) method is characterized as a non-invasive treatment modality that transmits gentle electrical impulses to the vestibular nerve, a critical neurological route, to impact brain areas responsible for sleep regulation without requiring surgery or medication. An example of this is the launch in October 2024 by Neurovalens Ltd., a health-tech enterprise based in the UK, of Modius Sleep, an FDA-cleared non-invasive device developed for managing chronic insomnia through electrical vestibular nerve stimulation (VeNS). This medical device, worn like a headset, is utilized for approximately 30 minutes nightly, emitting safe electrical signals to the vestibular nerve to modulate the hypothalamus and brainstem regions that govern circadian rhythm and sleep cycles, thereby assisting users in achieving quicker sleep onset and extended sleep duration.

Sleep Disorder Market Company Landscape And Strategic Competition

Major companies operating in the sleep disorder market are Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Biogen Inc., Union Chimique Belge S.A., Sun Pharmaceutical Industries Ltd., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Limited, H. Lundbeck A/S, Sumitomo Pharma Co. Ltd., Neurocrine Biosciences Inc., Harmony Biosciences Holdings Inc., Vanda Pharmaceuticals Inc.

Access The Complete Sleep Disorder Market Report:

https://www.thebusinessresearchcompany.com/report/sleep-disorder-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

Sleep Disorder Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the sleep disorder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sleep disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.